Jeremy Weingarten, MD
Sleep Medicine · Brooklyn, NYNPI 1316134489
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (53.5%), food and beverage and education — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 69.6% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $1,180, more than ten times the $97 reported in 2019. That places this record below the midpoint for sleep medicine clinicians in NY, where the typical reported total is $1,050.
Across 14 payments — averaging $101.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$984
- Itamar Medical Inc$196
- Actelion Pharmaceuticals US, Inc.$100
- Novartis$49
- GSK$24
- Insmed, Inc.$24
- plus $39 from 2 others
What the payments were for
- Travel & lodging$75754%
- Food & beverage$55839%
- Education$1007%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 6 | $984 |
| Itamar Medical Inc | 1 | $196 |
| Actelion Pharmaceuticals US, Inc. | 1 | $100 |
| Novartis | 2 | $49 |
| GSK | 1 | $24 |
| Insmed, Inc. | 1 | $24 |
| La Jolla Pharmaceutical Company | 1 | $20 |
| Coaptech, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$860
- WatchPATONE$196
How this compares
$1,415 in reported general payments places this provider in the 50th percentile of 81 sleep medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AmbienZolpidem Tartrate | 14 | $8,782 |
| Modafinil | 27 | $2,018 |
| Doxepin Hcl | 14 | $1,637 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $457 |
| Armodafinil | 11 | $435 |
| Zolpidem Tartrate | 33 | $228 |
| Zaleplon | 18 | $211 |
| Temazepam | 28 | $146 |
| Trazodone Hcl | 14 | $115 |
| Clonazepam | 11 | $83 |
| Gabapentin | 11 | $55 |
| Fluticasone Propionate | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Brooklyn
- Deepak VadhanBrooklyn$11K
- Jeanne DamianBrooklyn$338
- Irina PetrenkoBrooklyn$329
- David RapoportNew York$313K
- Ofer JacobowitzNew York$141K
- Qanta AhmedMineola$83K
- Andrew WestwoodNew York$82K
- Omar BurschtinNew York$71K
- Maha AhmadNew York$38K
- Daniel BaroneNew York$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.